News Update – FDA Approves New Treatment for Relapsing Forms of MS

[MSAA_archived]

TG Therapeutics has announced that the United States FDA has approved Briumvi™ (ublituximab-xiiy) for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting MS, and active secondary-progressive MS.

To learn more, please visit: mymsaa.org/news/fda-approve...